Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS)
- PMID: 28587586
- DOI: 10.1177/0961203317713142
Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS)
Abstract
The prevalence of depressive symptoms in patients with systemic lupus erythematosus (SLE) varies widely between different cohorts (17-75%), primarily due to factors such as the heterogeneity of the samples and the instruments used to detect depressive symptoms. Most of these instruments are self-administered questionnaires that have different characteristics and approaches to depressive symptoms. This study aimed to evaluate gender differences in the performance of three questionnaires used to assess depressive symptoms in patients with SLE: the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS). This study included 54 male and 54 female SLE patients. Depressive symptoms were assessed using BDI (cutoffs 13 and 15), CES-D and HADS. The gold standard method used was the diagnostic criteria of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. Regarding the performance of the BDI questionnaire, no significant differences in sensitivity or specificity were found between the genders. The specificity of the CES-D questionnaire was significantly greater for the male group (83% vs. 62.5%, p = 0.0309), and its sensitivity was non-significantly higher for the female group (92.9% for women and 71.4% for men; p = 0.2474). Regarding the performance of the HADS, we found similar sensitivities between the genders (71.4%) but a higher specificity among the men (95.7% in men and 82.5% in women, p = 0.0741). In conclusion, our results suggest the presence of gender differences in the performance of the questionnaires in SLE patients. The BDI had the most similar performances between the male and female groups. In contrast, the CES-D and HADS-D showed considerable variation in performances between men and women with SLE.
Keywords: Depression; gender; systemic lupus erythematosus.
Similar articles
-
Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life.Lupus. 2016 Oct;25(12):1315-27. doi: 10.1177/0961203316638934. Epub 2016 Mar 16. Lupus. 2016. PMID: 26989166
-
Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus.Rheumatol Int. 2017 Dec;37(12):1999-2004. doi: 10.1007/s00296-017-3819-x. Epub 2017 Sep 22. Rheumatol Int. 2017. PMID: 28940018 Review.
-
Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus.Semin Arthritis Rheum. 2019 Oct;49(2):260-266. doi: 10.1016/j.semarthrit.2019.03.004. Epub 2019 Mar 9. Semin Arthritis Rheum. 2019. PMID: 30940467
-
Active disease is independently associated with more severe anxiety rather than depressive symptoms in patients with systemic lupus erythematosus.Lupus. 2015 Nov;24(13):1392-9. doi: 10.1177/0961203315591026. Epub 2015 Jun 17. Lupus. 2015. PMID: 26085594
-
Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S454-66. doi: 10.1002/acr.20556. Arthritis Care Res (Hoboken). 2011. PMID: 22588766 Review. No abstract available.
Cited by
-
Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates.Front Immunol. 2024 May 17;15:1324987. doi: 10.3389/fimmu.2024.1324987. eCollection 2024. Front Immunol. 2024. PMID: 38827735 Free PMC article.
-
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study.Lupus. 2024 Sep;33(10):1025-1033. doi: 10.1177/09612033241273082. Lupus. 2024. PMID: 39279055 Free PMC article.
-
Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.Int J Clin Pharm. 2019 Oct;41(5):1247-1255. doi: 10.1007/s11096-019-00870-y. Epub 2019 Jun 25. Int J Clin Pharm. 2019. PMID: 31240553 Clinical Trial.
-
Assessing quality of life in pediatric fibrous dysplasia and McCune Albright syndrome: PEDS-QL and HADS data from the Fibrous Dysplasia Foundation Patient Registry.J Patient Rep Outcomes. 2021 Apr 12;5(1):34. doi: 10.1186/s41687-021-00304-2. J Patient Rep Outcomes. 2021. PMID: 33846865 Free PMC article.
-
Social determinants of depression in systemic lupus erythematosus: A systematic scoping review.Lupus. 2023 Jan;32(1):23-41. doi: 10.1177/09612033221135145. Epub 2022 Oct 22. Lupus. 2023. PMID: 36274579 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical